Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER α and β subtypes via an Sp1 site

Abstract

Through the analysis of the transient expression of the luciferase reporter gene in HeLa cells, an evaluation has been made of the transcriptional activity of oestrogens and of selective oestrogen receptor (ER) modulators (SERMs), mediated by the α and β isoforms of the ER, on the epidermal growth factor receptor gene promoter. Oestrogen-activated ERβ presents a lower transcriptional activity compared with ERα, probably due to structural differences in the AF-1 regions of the receptors. Also SERMs induce different responses depending on the receptor isoform bound. Indeed, the phyto-oestrogens, genistein and daidzein, act as weak agonists of the oestrogenic activity via ERα, but as full agonists when bound to ERβ. The synthetic SERM 4OH-tamoxifen, on the other hand, displays an opposite behaviour since it exerts a full agonist action through ERα, but acts as a full antagonist via ERβ. As we have previously shown for ERα, an ERβ/Sp1 functional synergism has also been highlighted, by means of gel mobility shift assays. Moreover, our results show that the sensitivity of target tissues to oestrogens and SERMs can be affected by coexpression of ERs, depending on the formation of appropriate levels of homo- and heterodimers, thus providing a useful approach to predict the effects of hormonal treatment.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA and Struhl K . (1995). Current Protocols in Molecular Biology, unit 9.6.10-9.6.19. Wiley Interscience: New York.

    Google Scholar 

  • Beato M . (1989). Cell, 56, 335–344.

  • Bramlett KS, Wu Y and Burris T . (2001). Mol. Endocrinol., 15, 909–922.

  • Cosman F and Lindsay R . (1999). Endocr. Rev., 20, 418–434.

  • De Graffenried LA, Hilsenbeck SG and Fuqua SAW . (2002). J. Steroid Biochem. Mol. Biol., 82, 7–18.

  • De Wet JR, Wood KV, De Luca M, Helinski DR and Subramani S . (1987). Cell, 54, 313–323.

  • Dong L, Wang W, Wang F, Stoner M, Reed JC, Harigai M, Samudio I, Kladde MP, Vyhlidal C and Safe S . (1999). J. Biol. Chem., 274, 32099–32107.

  • Enmark E, Pelto-Huikko M, Grandien K, Lagerkrantz S, Lagerkrantz J, Fried G, Nordenskjold M and Gustafsson J-A . (1997). J. Clin. Endocrinol. Metab., 82, 4258–4265.

  • Evans RM . (1988). Science, 240, 889–895.

  • Green S, Walter P, Kumar V, Krust A, Bornert J-M, Argos P and Chambon P . (1986). Nature, 320, 134–139.

  • Hall JM and McDonnell DP . (1999). Endocrinology, 140, 5566–5578.

  • Hudson LG, Santon JB and Gill GN . (1989). Mol. Endocrinol., 3, 400–408.

  • Hudson LG, Santon JB, Glass CK and Gill GN . (1990a). Cell, 62, 1165–1175.

  • Hudson LG, Thompson KL, Xu J and Gill GN . (1990b). Proc. Natl. Acad. Sci. USA, 87, 7536–7540.

  • Kim K, Thu N, Saville B and Safe S . (2003). Mol. Endocrinol., 17, 804–817.

  • Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S and Gustafsson J-A . (1997). Endocrinology, 138, 863–870.

  • Kuiper GGJM, Lemmen JG, Carlsson B, Corton JC, Safe SH, Van Der Saag PT, Van Der Burg B and Gustafsson J-A . (1998). Endocrinology, 139, 4252–4263.

  • Kurzer MS and Xu X . (1997). Annu. Rev. Nutr., 17, 353–381.

  • Lingham RB, Stancel GM and Loose-Mitchell DS . (1988). Mol. Endocrinol., 2, 230–235.

  • Maniatis T, Fritsch EF and Sambrook J . (1982). Molecular Cloning: a Laboratory Manual, unit Unit 16.66-16.67. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.

    Google Scholar 

  • Manolagas SC and Kousteni S . (2001). Endocrinology, 142, 2200–2204.

  • McInerney EM, Weis KE, Sun J, Mosselman S and Katzenellenbogen BS . (1998). Endocrinology, 139, 4513–4522.

  • Mosselman S, Polman J and Dijkema R . (1996). FEBS Lett., 392, 49–53.

  • Neal DE, Bennett MK, Hall RR, Marsh C, Abel PD, Sainsbury JRC and Harris AL . (1985). Lancet, 1, 366–368.

  • Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ and Scanlan TS . (1997). Science, 277, 1508–1510.

  • Routledge EJ, White R, Parker MG and Sumpter J . (2000). J. Biol. Chem., 275, 35986–35993.

  • Salvatori L, Ravenna L, Felli MP, Cardillo MR, Russo MA, Frati L, Gulino A and Petrangeli E . (2000). Endocrinology, 141, 2266–2274.

  • Saville B, Wormke M, Wang F, Nguyen T, Enmark E, Kuiper G, Gustafsson J-A and Safe S . (2000). J. Biol. Chem., 275, 5379–5387.

  • Schreiber E, Matthias P, Muller MM and Schaffner W . (1989). Nucleic Acids Res., 17, 6419.

  • Sun J, Meyers MJ, Fink BE, Rajendran R, Katzenellenbogen JA and Katzenellenbogen B . (1999). Endocrinology, 140, 800–804.

  • Tora L, Mullick A, Metzger D, Ponglikitmongkol M, Park I and Chambon P . (1989). EMBO J., 8, 1981–1986.

  • Truss M and Beato M . (1993). Endocr. Rev., 14, 459–479.

  • Van den Wijngaard A, Mulder WR, Dijkema R, Boersma CJC, Mosselman S, van Zoelen EJJ and Olijve W . (2000). Mol. Endocrinol., 14, 623–633.

  • Weihua Z, Saji S, Makinen S, Cheng G, Jensen EV, Warner M and Gustafsson J-A . (2000). Proc. Natl. Acad. Sci. USA, 97, 5936–5941.

  • Yarden R, Lauber AH, El-Ashry D and Chrysogelos SA . (1996). Endocrinology, 137, 2739–2747.

  • Yasui W, Hata J, Yokozaki H, Nakatani H, Ochiai A, Ito H and Tahara E . (1988). Int. J. Cancer, 41, 211–217.

Download references

Acknowledgements

This work was supported in part by grants from ADM, Decatur, Illinois, and in part by grants from CNR, Agenzia 2000 C008B98003.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Luisa Salvatori.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salvatori, L., Pallante, P., Ravenna, L. et al. Oestrogens and selective oestrogen receptor (ER) modulators regulate EGF receptor gene expression through human ER α and β subtypes via an Sp1 site. Oncogene 22, 4875–4881 (2003). https://doi.org/10.1038/sj.onc.1206784

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206784

Keywords

This article is cited by

Search

Quick links